Korean researchers have analyzed the effects of nanolastics on the metabolism of offspring.The Korea Research Institute of Bioscience and Biotechnology (KRIBB) said its research team, led by Dr. Lee Da-yong of the Center for Rare and Difficult Diseases, has found that nanoplastics are transferred to
The treatment of biliary tract cancer, one of the cancers with a poor prognosis, is changing rapidly. Immunotherapies and targeted anticancer drugs have been developed in a rush. However, none of them have been covered by health insurance in Korea, and patients and medical workers complain that the
Celltrion, a Korean biopharmaceutical giant, said it has launched a 20-mg dosage formulation of its biosimilar Yuflyma (adalimumab) to treat autoimmune diseases in pediatric patients in the U.S.Yuflyma 20mg is the same high-concentration (100mg/mL) formulation as the 40mg and 80 mg, which were launc
Coreline Soft, a medical AI company, has begun to generate results by strengthening its solution supply contracts and partnerships with leading European hospitals.Coreline Soft said Thursday that it has signed a contract to supply its flagship product, AVIEW LCS Plus, a simultaneous diagnosis soluti
Medical school professors repeatedly point out that the government's decision to increase in the medical school enrollment quota will compromise the quality of medical education.Some experts have gone so far as to express concerns that such actions could regress medical education by a century.As par
Takeda Pharmaceuticals Korea said on Thursday that Livtencity (ingredient: maribavir), a tablet for cytomegalovirus (CMV) infection and disease after transplantation, will be covered by Korean national health insurance starting April 1.Livtencity is an antiviral pill developed to treat CMV infection
There are no foods that you shouldn’t eat in the morning. A common concern is that eating a banana on an empty stomach in the morning will cause magnesium and potassium to enter the blood, upsetting the balance. However, there is no evidence to support this claim. One banana contains 300 mg of potas
Trainee pediatricians who have left hospitals have come forward to demand a fundamental package to resuscitate essential medicine. They say they could not help but quit to block the government's wrong policies.Interns and residents who walked off their jobs at pediatrics departments at 18 major hosp
HK inno.N said it plans to present the interim preclinical research findings on IN-119873, its next-generation allosteric EGFR-tyrosine kinase inhibitor (EGFR-TKI) candidate, targeting non-small cell lung cancer (NSCLC) patients with the L858R genetic mutation, during the upcoming annual meeting of
Rophibio, a Korean biologics manufacturer, said Wednesday that it has entered into an agreement with Avantor, a U.S. biotech company, to supply raw materials and provide development support for a biosimilar referencing Keytruda.Keytruda (pembrolizumab) is MSD's blockbuster cancer medicine.The proces
Korean researchers identified the mechanism of brain tumor recurrence through cancer protein genome analysis "for the first time in the world," a local cancer hospital said. The National Cancer Center (NCC) said Wednesday that Dr. Park Jong-bae, head of the Cancer Proteomics Division, and Dr. Kim Ky
FutureChem said Wednesday that its radiopharmaceutical candidate FC705 for treating prostate cancer has been granted Global Innovative Products on Fast Track (GIFT) designation by the Ministry of Food and Drug Safety.GIFT is a support system to bring highly innovative drugs, such as treatments for l
Lotte Biologics said it entered a partnership with Syracuse University to co-develop an educational program.Syracuse University, a U.S. private institution consisting of 13 schools and colleges, boasts distinguished alumni such as President Joe Biden and New York Governor Kathy Hochul.Under the acco
As life expectancy increases, dental implants' "long-term stability" is becoming increasingly important. That’s because as people age, the number of missing teeth increases, and as life expectancy also increases, people must be able to use implants for longer periods.Straumann Korea, the Korean offs
Pfizer Korea’s attempts to expand reimbursement for its third-generation ALK inhibitor Lorviqua (lorlatinib) do not seem to bear fruit easily, according to industry sources.Some analysts have speculated that Pfizer Korea might have made a strategic choice in the drug price negotiations due to Lorviq
Bridge Biotherapeutics said Wednesday it has signed collaborative research agreements with the University of Colorado and Emory University to explore the potential for expanding the indications of BBT-877, an autotaxin inhibitor, as an immuno-oncology agent.The company added that the joint researche
The rift between the government and the medical community is expected to deepen as Lim Hyun-taek, the president-elect of the Korean Medical Association (KMA), has firmly demanded a presidential apology and the dismissal of both the Minister and Vice Minister of Health and Welfare if the government w
Myongji Hospital and Rokit Healthcare, a company specializing in organ regeneration, have agreed to join forces to research and develop diabetic foot treatment technology using 3D bioprinting.Myongji Hospital President Kim Jin-goo and Rokit Healthcare Chairman and CEO You Seok-hwan signed the agreem
Hanmi Group Chairman Song Young-sook and her daughter have gained a decisive edge in the ongoing management conflict within the founding family after securing support from the National Pension Service (NPS), which has emerged as a deciding factor in this corporate governance battle.On Tuesday evenin
If a liver cancer patient has undergone third-line therapy following immunotherapies Tecentriq (atezolizumab) and Avastin (bevacizumab), but the liver cancer has progressed, leading to lung metastasis, what is the subsequent treatment plan?What is the rate of patients who do not respond to this thir